Published in J Virol on February 01, 2002
Interactions between viral nonstructural proteins and host protein hVAP-33 mediate the formation of hepatitis C virus RNA replication complex on lipid raft. J Virol (2004) 2.89
Hepatitis C virus triggers mitochondrial permeability transition with production of reactive oxygen species, leading to DNA damage and STAT3 activation. J Virol (2006) 1.44
Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses. J Virol (2003) 1.13
Apoptosis of activated CD4+ and CD8+ T cells is enhanced by co-culture with hepatocytes expressing hepatitis C virus (HCV) structural proteins through FasL induction. Virology (2005) 0.95
Retracted SOCS1 and SOCS3 are targeted by hepatitis C virus core/gC1qR ligation to inhibit T-cell function. J Virol (2005) 0.94
Inhibition of intrahepatic gamma interferon production by hepatitis C virus nonstructural protein 5A in transgenic mice. J Virol (2009) 0.94
The wild-type hepatitis C virus core inhibits initiation of antigen-specific T- and B-cell immune responses in BALB/c mice. Clin Vaccine Immunol (2010) 0.84
Expression of hepatitis C virus core protein in hepatocytes does not modulate proliferation or apoptosis of CD8+ T cells. Yonsei Med J (2005) 0.77
A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A (1998) 24.58
Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol (1995) 10.65
Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med (2000) 9.36
MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity (1994) 4.65
IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J Immunol (1998) 3.56
The Taiwanese hepatitis C virus genome: sequence determination and mapping the 5' termini of viral genomic and antigenomic RNA. Virology (1992) 2.88
Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest. J Immunol (1994) 2.87
Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo. Virology (1998) 2.76
Rapid colorimetric assay for cell viability: application to the quantitation of cytotoxic and growth inhibitory lymphokines. J Immunol Methods (1984) 2.38
Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol (1998) 2.28
Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv Immunol (1998) 2.23
Use of the human elongation factor 1 alpha promoter as a versatile and efficient expression system. Gene (1990) 2.14
Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistence. J Immunol (1999) 1.73
Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation. J Virol (1999) 1.72
IL-18 accounts for both TNF-alpha- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. J Immunol (1997) 1.62
NK cells cause liver injury and facilitate the induction of T cell-mediated immunity to a viral liver infection. J Immunol (2000) 1.60
Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Res (1995) 1.58
Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. Virology (1997) 1.49
Suppression of apoptotic cell death by hepatitis C virus core protein. Virology (1996) 1.46
Inhibition of tumor necrosis factor (TNF-alpha)-mediated apoptosis by hepatitis C virus core protein. J Biol Chem (1998) 1.40
Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector. Eur J Immunol (1995) 1.36
The HCV core protein acts as a positive regulator of fas-mediated apoptosis in a human lymphoblastoid T cell line. Virology (2000) 1.23
Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C. Hepatology (1998) 1.09
Fas-mediated apoptosis causes elimination of virus-specific cytotoxic T cells in the virus-infected liver. J Immunol (2001) 1.07
Fas- and tumor necrosis factor receptor 1-dependent but not perforin-dependent pathways cause injury in livers infected with an adenovirus construct in mice. Hepatology (2000) 0.85
Pathology of hepatitis C. Intervirology (1994) 0.82
Quantitation of DNA fragmentation using fiberglass filters. Anal Biochem (1989) 0.81
TNF-alpha bifunctionally induces proliferation in primary hepatocytes: role of cell anchorage and spreading. J Immunol (1997) 0.80
Interactions between viral nonstructural proteins and host protein hVAP-33 mediate the formation of hepatitis C virus RNA replication complex on lipid raft. J Virol (2004) 2.89
Hepatitis C virus RNA replication occurs on a detergent-resistant membrane that cofractionates with caveolin-2. J Virol (2003) 2.86
Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection. J Virol (2003) 2.60
Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins. Virology (2002) 2.55
Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc Natl Acad Sci U S A (2004) 2.30
Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts. Virology (2004) 2.28
Identification of a ribavirin-resistant NS5B mutation of hepatitis C virus during ribavirin monotherapy. Hepatology (2003) 2.14
Morbidity and mortality of infants with very low birth weight in Japan: center variation. Pediatrics (2006) 2.04
Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B. J Virol (2005) 1.86
The effect of chronic or intermittent hypoxia on cognition in childhood: a review of the evidence. Pediatrics (2004) 1.85
High sensitivity of CD4+CD25+ regulatory T cells to extracellular metabolites nicotinamide adenine dinucleotide and ATP: a role for P2X7 receptors. J Immunol (2005) 1.74
Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cells. Hepatology (2004) 1.71
Autoantibodies and cell-mediated autoimmunity to NMDA-type GluRepsilon2 in patients with Rasmussen's encephalitis and chronic progressive epilepsia partialis continua. Epilepsia (2005) 1.65
Critical role of virion-associated cholesterol and sphingolipid in hepatitis C virus infection. J Virol (2008) 1.65
Thoracic and cardiovascular surgery in Japan during 2012 : annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg (2014) 1.65
Palmitoylation and polymerization of hepatitis C virus NS4B protein. J Virol (2006) 1.59
Activation of anti-hepatitis C virus responses via Toll-like receptor 7. Proc Natl Acad Sci U S A (2006) 1.59
Angiographic findings and surgical treatments of coronary artery involvement in Takayasu arteritis. J Thorac Cardiovasc Surg (2003) 1.54
Is avian influenza A (H7N9) virus staggering its way to humans? J Formos Med Assoc (2013) 1.52
Hepatitis C virus triggers mitochondrial permeability transition with production of reactive oxygen species, leading to DNA damage and STAT3 activation. J Virol (2006) 1.44
Association of hepatitis C virus replication complexes with microtubules and actin filaments is dependent on the interaction of NS3 and NS5A. J Virol (2008) 1.43
The percentage of superantigen-reactive T cells in peripheral blood significantly decreases before massively increasing in patients with neonatal TSS-like exanthematous disease in the early acute phase. J Infect Chemother (2002) 1.41
Hepatitis C virus E2-CD81 interaction induces hypermutation of the immunoglobulin gene in B cells. J Virol (2005) 1.40
Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6. J Virol (2006) 1.38
Human monoclonal antibody to hepatitis C virus E1 glycoprotein that blocks virus attachment and viral infectivity. J Virol (2004) 1.37
Interaction with a ubiquitin-like protein enhances the ubiquitination and degradation of hepatitis C virus RNA-dependent RNA polymerase. J Virol (2003) 1.32
Ubiquitination and deubiquitination of NP protein regulates influenza A virus RNA replication. EMBO J (2010) 1.30
Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes. J Virol (2004) 1.30
The hepatitis C virus persistence: how to evade the immune system? J Biosci (2003) 1.29
Rolling circle replication of hepatitis delta virus RNA is carried out by two different cellular RNA polymerases. J Virol (2002) 1.28
Rab5 and class III phosphoinositide 3-kinase Vps34 are involved in hepatitis C virus NS4B-induced autophagy. J Virol (2011) 1.27
Modulation of gene expression by human cytosolic tRNase Z(L) through 5'-half-tRNA. PLoS One (2009) 1.26
Fine-scale staging of T cell lineage commitment in adult mouse thymus. J Immunol (2010) 1.25
High-throughput identification of compounds targeting influenza RNA-dependent RNA polymerase activity. Proc Natl Acad Sci U S A (2010) 1.24
International comparison of care for very low birth weight infants: parents' perceptions of counseling and decision-making. Pediatrics (2005) 1.23
Detection of a novel unglycosylated form of hepatitis C virus E2 envelope protein that is located in the cytosol and interacts with PKR. J Virol (2002) 1.22
Activated natural killer T cells induce liver injury by Fas and tumor necrosis factor-alpha during alcohol consumption. Gastroenterology (2004) 1.21
c-Jun mediates hepatitis C virus hepatocarcinogenesis through signal transducer and activator of transcription 3 and nitric oxide-dependent impairment of oxidative DNA repair. Hepatology (2010) 1.20
Molecular epidemiology of methicillin-resistant Staphylococcus aureus strains causing neonatal toxic shock syndrome-like exanthematous disease in neonatal and perinatal wards. J Clin Microbiol (2003) 1.18
Hepatitis C virus proteins: direct link to hepatic oxidative stress, steatosis, carcinogenesis and more. Gastroenterology (2002) 1.17
Hepatitis C virus NS3/4A protein interacts with ATM, impairs DNA repair and enhances sensitivity to ionizing radiation. Virology (2007) 1.16
Hepatitis C virus inhibits DNA damage repair through reactive oxygen and nitrogen species and by interfering with the ATM-NBS1/Mre11/Rad50 DNA repair pathway in monocytes and hepatocytes. J Immunol (2010) 1.16
The ubiquitin-proteasome system facilitates the transfer of murine coronavirus from endosome to cytoplasm during virus entry. J Virol (2005) 1.15
Hepatitis C virus infects T cells and affects interferon-gamma signaling in T cell lines. Virology (2006) 1.14
Psychological stress-induced oxidative stress as a model of sub-healthy condition and the effect of TCM. Evid Based Complement Alternat Med (2006) 1.14
IP-10 and Mig facilitate accumulation of T cells in the virus-infected liver. Cell Immunol (2002) 1.13
Genomic but not antigenomic hepatitis delta virus RNA is preferentially exported from the nucleus immediately after synthesis and processing. J Virol (2002) 1.10
Current status and evaluation of transnasal esophagogastroduodenoscopy. Dig Endosc (2009) 1.10
Polo-like kinase 1 is involved in hepatitis C virus replication by hyperphosphorylating NS5A. J Virol (2010) 1.09
Nuclear Rho kinase, ROCK2, targets p300 acetyltransferase. J Biol Chem (2006) 1.09
Hepatitis delta virus antigen is methylated at arginine residues, and methylation regulates subcellular localization and RNA replication. J Virol (2004) 1.08
Polypyrimidine-tract-binding protein affects transcription but not translation of mouse hepatitis virus RNA. Virology (2002) 1.08
P2X7 receptors regulate NKT cells in autoimmune hepatitis. J Immunol (2006) 1.07
Mutagenic and inhibitory effects of ribavirin on hepatitis C virus RNA polymerase. Biochemistry (2003) 1.06
Polypyrimidine-tract-binding protein is a component of the HCV RNA replication complex and necessary for RNA synthesis. J Biomed Sci (2006) 1.06
Physician counselling practices and decision-making for extremely preterm infants in the Pacific Rim. J Paediatr Child Health (2005) 1.05
Pooled RNAi screen identifies ubiquitin ligase Itch as crucial for influenza A virus release from the endosome during virus entry. Proc Natl Acad Sci U S A (2013) 1.04
Hepatitis C virus (HCV)-induced immunoglobulin hypermutation reduces the affinity and neutralizing activities of antibodies against HCV envelope protein. J Virol (2008) 1.03
The C-terminal transmembrane domain of hepatitis C virus (HCV) RNA polymerase is essential for HCV replication in vivo. J Virol (2004) 1.03
Comparison of serum cortisol concentrations in preterm infants with or without late-onset circulatory collapse due to adrenal insufficiency of prematurity. Pediatr Res (2008) 1.02
Hepatitis C virus IRES-dependent translation is insensitive to an eIF2alpha-independent mechanism of inhibition by interferon in hepatocyte cell lines. Virology (2002) 1.01
Nonstructural 5A protein of hepatitis C virus modulates tumor necrosis factor alpha-stimulated nuclear factor kappa B activation. J Biol Chem (2002) 1.00
Hepatitis C virus nonstructural 5B protein regulates tumor necrosis factor alpha signaling through effects on cellular IkappaB kinase. Mol Cell Biol (2006) 1.00
P2X7 receptor-dependent and -independent T cell death is induced by nicotinamide adenine dinucleotide. J Immunol (2005) 1.00
Molecular pathogenesis of Gilbert's syndrome: decreased TATA-binding protein binding affinity of UGT1A1 gene promoter. Pharmacogenet Genomics (2007) 1.00
Large hepatitis delta antigen is not a suppressor of hepatitis delta virus RNA synthesis once RNA replication is established. J Virol (2002) 0.99
Feasibility and tolerance of 2-way and 4-way angulation videoscopes for unsedated patients undergoing transnasal EGD in GI cancer screening. Gastrointest Endosc (2008) 0.99
P2X7 receptor expression levels determine lethal effects of a purine based danger signal in T lymphocytes. Cell Immunol (2007) 0.99
Bilateral versus unilateral internal mammary revascularization in patients with diabetes. Circulation (2003) 0.98
Hepatitis C virus egress and release depend on endosomal trafficking of core protein. J Virol (2010) 0.98
Annexin A2 is involved in the formation of hepatitis C virus replication complex on the lipid raft. J Virol (2012) 0.97
RNA-templated replication of hepatitis delta virus: genomic and antigenomic RNAs associate with different nuclear bodies. J Virol (2006) 0.97
Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin. J Pediatr (2003) 0.97
Transient activation of the PI3K-AKT pathway by hepatitis C virus to enhance viral entry. J Biol Chem (2012) 0.97
SYNCRIP, a member of the heterogeneous nuclear ribonucleoprotein family, is involved in mouse hepatitis virus RNA synthesis. J Virol (2004) 0.97
Enzymatic characterization of the full-length and C-terminally truncated hepatitis C virus RNA polymerases: function of the last 21 amino acids of the C terminus in template binding and RNA synthesis. Biochemistry (2004) 0.97
Multiple type A/B heterogeneous nuclear ribonucleoproteins (hnRNPs) can replace hnRNP A1 in mouse hepatitis virus RNA synthesis. J Virol (2003) 0.96
Murine coronavirus requires lipid rafts for virus entry and cell-cell fusion but not for virus release. J Virol (2005) 0.96
Involvement of creatine kinase B in hepatitis C virus genome replication through interaction with the viral NS4A protein. J Virol (2009) 0.96
Human cytosolic tRNase ZL can downregulate gene expression through miRNA. FEBS Lett (2009) 0.95
Prevention of respiratory syncytial virus infections in high-risk infants by monoclonal antibody (palivizumab). Pediatr Int (2002) 0.95
Positron emission tomography for predicting malignancy of sinonasal inverted papilloma. Clin Nucl Med (2007) 0.95
Treatment of HCV-related mantle-cell lymphoma with ribavirin and pegylated interferon Alfa. N Engl J Med (2003) 0.95
Modulation of doxorubicin-induced cardiac dysfunction in dominant-negative p38α mitogen-activated protein kinase mice. Free Radic Biol Med (2010) 0.94
Prevention of oxidative injury in PC12 cells by a traditional Chinese medicine, Shengmai San, as a model of an antioxidant-based composite formula. Biol Pharm Bull (2003) 0.94
SYNCRIP (synaptotagmin-binding, cytoplasmic RNA-interacting protein) is a host factor involved in hepatitis C virus RNA replication. Virology (2009) 0.94
Identification of RNA ligands that bind hepatitis C virus polymerase selectively and inhibit its RNA synthesis from the natural viral RNA templates. Virology (2003) 0.94
Modification of small hepatitis delta virus antigen by SUMO protein. J Virol (2009) 0.92
From the Japan association of research on developmental care. Pediatrics (2013) 0.92
Hepatitis C virus infection of T cells inhibits proliferation and enhances fas-mediated apoptosis by down-regulating the expression of CD44 splicing variant 6. J Infect Dis (2009) 0.92
Hepatitis C virus causes uncoupling of mitotic checkpoint and chromosomal polyploidy through the Rb pathway. J Virol (2009) 0.91
Seasonal detection of human viruses and coliphage in Newport Bay, California. Appl Environ Microbiol (2007) 0.91
Objective assessment of skin tightening in Asians using a water-filtered near-infrared (1,000-1,800 nm) device with contact-cooling and freezer-stored gel. Clin Cosmet Investig Dermatol (2013) 0.91
Fatal hemophagocytic lymphohistiocytosis in an extremely-low-birthweight infant. Pediatr Int (2010) 0.90
HCV core expression in hepatocytes protects against autoimmune liver injury and promotes liver regeneration in mice. Hepatology (2006) 0.89